Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00108446 · ClinicalTrials.gov registry record · Phase 2
Characterization of Pain Processing Mechanisms in Irritable Bowel Syndrome
A Phase 2 study of Irritable Bowel Syndrome, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 2
- Development phase
- 1
- Study location
NCT00108446: Completed Phase 2 study of Irritable Bowel Syndrome, sponsored by US Department of Veterans Affairs.
NCT00108446 is a Phase 2 study of Irritable Bowel Syndrome that has completed, run by US Department of Veterans Affairs. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00108446, a Phase 2 study of Irritable Bowel Syndrome, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 1
- Study location
Study Summary
This study is being done to collect new information on irritable bowel syndrome, a disease that causes abdominal pain that does get better with treatment or keeps coming back ("chronic"). To better understand what causes the irritable bowel syndrome, we are studying drugs used to treat pain, dextromethorphan, naloxone, fentanyl, and lidocaine. We will study the effects these drugs have on experimental pain. Dextromethorphan is used in non-prescription cough syrups. Naloxone is used for reversing the effects of narcotic pain relievers. Fentanyl is a narcotic used to treat pain and to make a person relaxed (sedated) before anesthesia. The purpose of this study is to see what kinds of pain are affected by these drugs in persons who have irritable bowel syndrome and persons who do not have this problem.
Conditions Studied
Interventions
- DRUG fentanyl
- DRUG dextromethorphan
- DRUG naloxone
- DRUG lidocaine
Study Locations (1)
Florida
- Malcom Randall VAMC - Gainesville
Trial Details
| Field | Value |
|---|---|
| Start Date | 2003-10 |
| Est. Completion | 2006-03 |
| Phase | Phase 2 |
What the finished NCT00108446 record still lists
NCT00108446 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 1 condition, with Irritable Bowel Syndrome appearing as the primary indexed condition, and to 4 interventions - of which fentanyl is the first listed.
NCT00108446 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT00108446 about?
NCT00108446 is a clinical study titled "Characterization of Pain Processing Mechanisms in Irritable Bowel Syndrome". This study is being done to collect new information on irritable bowel syndrome, a disease that causes abdominal pain that does get better with treatment or keeps coming back ("chronic"). To better understand what causes the irritable bowel syndrome, we are studying drugs used to treat pain, dextrom...
What is the current status of trial NCT00108446?
This trial is currently completed. It is a Phase 2 study. The study started on 2003-10. Estimated completion is 2006-03.
What conditions does trial NCT00108446 study?
This clinical trial studies the following conditions: Irritable Bowel Syndrome.
What interventions are being tested in trial NCT00108446?
The interventions under investigation include: fentanyl (DRUG), dextromethorphan (DRUG), naloxone (DRUG), lidocaine (DRUG).
Who is sponsoring clinical trial NCT00108446?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00108446 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Irritable Bowel Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Psyllium in Pediatric IBS
RECRUITING · Phase 2
-
Fecal Microbiota Transplantation for IBS
RECRUITING · Phase 2
-
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children
RECRUITING · Phase 2
-
Assessment of Psilocybin (TRP-8802) in Concert With Psychotherapy in Patients With Irritable Bowel Syndrome (IBS)
ACTIVE NOT RECRUITING · Phase 2
-
Effect of BIO-K+ on Symptoms of Irritable Bowel Syndrome
COMPLETED · Phase 2
-
A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia